An international team of researchers has found that an antibiotic commonly prescribed for patients with liver disease, called rifaximin, has led to the global emergence of an almost untreatable form ...
Researchers have developed a new technology that can hold an entire course of antibiotics in one tiny dose and deliver on demand just the right amount of medication that a particular patient needs to ...
A small molecular strand could hold the key to solving one of the greatest global health challenges. When bacteria develop resistance to antibiotics, it can be deadly, but researchers have now decoded ...
Researchers at Intermountain Health have been awarded a $356,000 grant from Merck, a global science and technology company ...
Researchers from the University of Waterloo have developed a new technology that can hold an entire course of antibiotics in ...